Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis
Zhen Yu Wong(Nottingham University Hospitals NHS Trust), Margaret Teng(National University of Singapore), Darren Jun Hao Tan(National University Hospital), Christen En Ya Ong(National University of Singapore), Douglas Chee(National University Health System), Wen Hui Lim(National University of Singapore), Mazen Noureddin(Methodist Hospital), Benjamin Koh(National University of Singapore), Elden Yen Hng Ong(National University of Singapore), Karn Wijarnpreecha(University of Arizona), Mark Muthiah(National University of Singapore), Kewin Tien Ho Siah(National University of Singapore), Benjamin Nah, Kai Qi Ou(Nottingham University Hospitals NHS Trust), Yu Jun Wong(National University of Singapore), Apichat Kaewdech(Prince of Songkla University), Cheng Han Ng(Kurume University), Jia Hong Koh(National University Hospital), Anand V. Kulkarni(Asian Institute of Gastroenterology), Daniel Q. Huang(National University of Singapore)
Cited by 23
Related Papers
The global burden of metabolic disease: Data from 2000 to 2019
|Cell Metabolism|2023|777
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
|Journal of Hepatology|2020|525
Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals
|The Journal of Clinical Endocrinology & Metabolism|2022|306
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
|Hepatology International|2020|295
Global burden of metabolic diseases, 1990–2021
|Metabolism|2024|294